Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment

Autor: Jiri Frohlich, Allan D. Sniderman, Anthony C Keech, J. E. Roeters Van Lennep, C. D. Furberg, Ana M. Wägner, Ingmar Jungner, Göran Walldius
Rok vydání: 2003
Předmět:
Zdroj: The Lancet. 361:777-780
ISSN: 0140-6736
Popis: More Nobel prizes have been awarded for the study of cholesterol than for any other molecule. Presently, concentration of LDL cholesterol is the fundamental index of risk of vascular disease. It is an estimate of the mass of cholesterol in the LDL fraction in plasma. By contrast, the value for apolipoprotein B is a measurement of the total number of atherogenic particles. Results of many studies show that apolipoprotein B is a better marker of risk of vascular disease and a better guide to the adequacy of statin treatment than any cholesterol index. Moreover, the ratio of apolipoprotein B/apolipoprotein A-1 seems superior to the ratio of total cholesterol/HDL cholesterol as an overall index of the risk of vascular disease. We review this evidence and include observations that were not previously published. The pathophysiological bases for the superiority of apolipoprotein B to cholesterol as a predictor of risk are reported elsewhere. 1
Databáze: OpenAIRE
Nepřihlášeným uživatelům se plný text nezobrazuje